SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-13-001478
Filing Date
2013-08-19
Accepted
2013-08-19 10:34:39
Documents
22
Period of Report
2013-08-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e611225_8k-retrophin.htm 8-K 21856
2 e611225_ex99-1.htm EX-99.1 16165
3 GRAPHIC presentation01.jpg GRAPHIC 83023
4 GRAPHIC presentation02.jpg GRAPHIC 375172
5 GRAPHIC presentation03.jpg GRAPHIC 102582
6 GRAPHIC presentation04.jpg GRAPHIC 178484
7 GRAPHIC presentation05.jpg GRAPHIC 159809
8 GRAPHIC presentation06.jpg GRAPHIC 159122
9 GRAPHIC presentation07.jpg GRAPHIC 140842
10 GRAPHIC presentation08.jpg GRAPHIC 217656
11 GRAPHIC presentation09.jpg GRAPHIC 173220
12 GRAPHIC presentation10.jpg GRAPHIC 184604
13 GRAPHIC presentation11.jpg GRAPHIC 164633
14 GRAPHIC presentation12.jpg GRAPHIC 160539
15 GRAPHIC presentation13.jpg GRAPHIC 144681
16 GRAPHIC presentation14.jpg GRAPHIC 179661
17 GRAPHIC presentation15.jpg GRAPHIC 113631
18 GRAPHIC presentation16.jpg GRAPHIC 99205
19 GRAPHIC presentation17.jpg GRAPHIC 233811
20 GRAPHIC presentation18.jpg GRAPHIC 119397
21 GRAPHIC presentation19.jpg GRAPHIC 122112
22 GRAPHIC presentation20.jpg GRAPHIC 83023
  Complete submission text file 0001193805-13-001478.txt   4444517
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 000-53293 | Film No.: 131047243
SIC: 2834 Pharmaceutical Preparations